Product containing precisely theophylline 175 mg/1 each prolonged-release oral tablet (clinical drug)
RxNorm 199809
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 199809 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing precisely theophylline 175 mg/1 each prolonged-release oral tablet (clinical drug).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Theophylline 175 mg Extended Release Oral Tablet
(Atom ID: 12348853)
Full form of descriptor (FN):
Product containing precisely theophylline 175 mg/1 each prolonged-release oral tablet (clinical drug)
(Atom ID: 10317675)
Designated preferred name (PT):
Theophylline 175 mg prolonged-release oral tablet
(Atom ID: 10321606)
Patient Education
Theophylline
Theophylline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.